Have a personal or library account? Click to login
Should we be screening for anti-Jsa? Cover

Should we be screening for anti-Jsa?

Immunohematology
Volume 27 (2011): Issue 3 (September 2011)
By: N.M. Nikolis,  F.N. Boctor,  W.A. Heaton and  J. Martone  
Paid access
|Mar 2020

Authors

N.M. Nikolis

Transfusion Service and Donor Services, North Shore University Hospital Department of Laboratories, Manhasset, USA

F.N. Boctor

Transfusion Service and Donor Services, North Shore University Hospital Department of Laboratories, Manhasset, USA

W.A. Heaton

Transfusion Service and Donor Services, North Shore University Hospital Department of Laboratories, Manhasset, USA

J. Martone

Transfusion Service and Donor Services, North Shore University Hospital Department of Laboratories, Manhasset, USA
DOI: https://doi.org/10.21307/immunohematology-2019-183 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 104 - 106
Published on: Mar 11, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Jsa,
antibody,
antigen,
low prevalence antigens,
antibody screening
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2020 N.M. Nikolis, F.N. Boctor, W.A. Heaton, J. Martone, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 27 (2011): Issue 3 (September 2011)